Jesus Shrestha, Keshav Raj Paudel, Hojjatollah Nazari, Vivek Dharwal, Sajad Razavi Bazaz, Matt D. Johansen, Kamal Dua, Philip M. Hansbro & Majid Ebrahimi Warkiani. (2023) Advanced models for respiratory disease and drug studies. Medicinal Research Reviews 43:5, pages 1470-1503.
Crossref
Mohamed Labib Salem, Ismail Atia & Nehal M. Elmashad. (2023) Higher cytotoxic activities of CD8+ T cells and natural killer cells from peripheral blood of early diagnosed lung cancer patients. BMC Immunology 24:1.
Crossref
Megan O’Shaughnessy, Orla Sheils & Anne-Marie Baird. (2023) The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs. International Journal of Molecular Sciences 24:15, pages 12296.
Crossref
Haiyi Deng, Jiating Deng, Xinqing Lin, Wenhui Guan, Ziying Lin, Yanli Qiu, Yilin Yang, Jianhui Wu, Guihuan Qiu, Ni Sun, Maolin Zhou, Jiaxi Deng, Xiaohong Xie, Zhanhong Xie, Ming Liu, Yinyin Qin, Yanbin Zhou & Chengzhi Zhou. (2023) A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case–Control Study. Clinical Drug Investigation 43:5, pages 347-357.
Crossref
Lauren H. Fairley, Shatarupa Das, Vivek Dharwal, Nadia Amorim, Karl J. Hegarty, Ridhima Wadhwa, Guntipally Mounika & Philip M. Hansbro. (2023) Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease. Antioxidants 12:4, pages 973.
Crossref
Xintong He, Ye Sun, Jianzhang Lu, Faiza Naz, Shenglin Ma & Jian Liu. (2023) Cytoplasmic DNAs: Sources, sensing, and roles in the development of lung inflammatory diseases and cancer. Frontiers in Immunology 14.
Crossref
Deepa Upreti, Susumu Ishiguro, Morgan Phillips, Ayaka Nakashima, Kengo Suzuki, Jeffrey Comer & Masaaki Tamura. (2023)
Euglena gracilis
Extract Protects From Tobacco Smoke Carcinogen-Induced Lung Cancer by Altering Gut Microbiota Metabolome
. Integrative Cancer Therapies 22.
Crossref
Francesco Nucera, Ilaria Salvato, Luca Ricciardi, Jessica Dal Col, Francesco Monaco, Phil M. Hansbro, Ian M. Adcock, Vincenzo Casolaro, Cristiana Stellato & Gaetano Caramori. 2023.
Kurtis F. Budden, Shaan L. Gellatly, Annalicia Vaughan, Nadia Amorim, Jay C. Horvat, Nicole G. Hansbro, David L. A. Wood, Philip Hugenholtz, Paul G. Dennis, Peter A. B. Wark & Philip M. Hansbro. (2022) Probiotic Bifidobacterium longum subsp. longum Protects against Cigarette Smoke-Induced Inflammation in Mice. International Journal of Molecular Sciences 24:1, pages 252.
Crossref
Mao Lin, Zongyao Huang, Yingfu Chen, Hongtao Xiao & Ting Wang. (2022) Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy. Frontiers in Immunology 13.
Crossref
Camila Freitas dos Santos, Mariana Gobbo Braz, Nayara Micarelli de Arruda, Laura Caram, Duelene Ludimila Nogueira, Suzana Erico Tanni, Irma de Godoy & Renata Ferrari. (2022) DNA damage and antioxidant capacity in COPD patients with and without lung cancer. PLOS ONE 17:11, pages e0275873.
Crossref
Ian A. Yang, Janet G. Shaw, Edward K.H. Stephens, Tian Mun Chee, Edwina E. Duhig, Rayleen V. Bowman, Gerard N. Olive, Henry M. Marshall & Kwun M. Fong. 2022. Lung Diseases and Cancer. Lung Diseases and Cancer
91
104
.
Akshad Balde, Se-Kwon Kim, Soottawat Benjakul & Rasool Abdul Nazeer. (2022) Pulmonary drug delivery applications of natural polysaccharide polymer derived nano/micro-carrier systems: A review. International Journal of Biological Macromolecules 220, pages 1464-1479.
Crossref
Yuan-rui Xu, An-long Wang & Ya-qing Li. (2022) Hypoxia-inducible factor 1-alpha is a driving mechanism linking chronic obstructive pulmonary disease to lung cancer. Frontiers in Oncology 12.
Crossref
Xiaoshan Su, Weijing Wu, Zhixing Zhu, Xiaoping Lin & Yiming Zeng. (2022) The effects of epithelial–mesenchymal transitions in COPD induced by cigarette smoke: an update. Respiratory Research 23:1.
Crossref
Honglin Cai, Tomotaka Sobue, Tetsuhisa Kitamura, Junko Ishihara, Utako Murai, Norie Sawada, Motoki Iwasaki, Taiki Yamaji, Manami Inoue & Shoichiro Tsugane. (2022) Dietary fibre intake is associated with reduced risk of lung cancer: a Japan public health centre-based prospective study (JPHC). International Journal of Epidemiology 51:4, pages 1142-1152.
Crossref
Jia-Qi He, Qin Chen, Sheng-Jun Wu, De-Qin Wang, Shen-Yingjie Zhang, Song-Zhao Zhang, Rui-Lin Chen, Jia-Feng Wang, Zhen Wang & Chen-Huan Yu. (2022) Potential Implications of the Lung Microbiota in Patients with Chronic Obstruction Pulmonary Disease and Non-Small Cell Lung Cancer. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Isabel UWAGBOE, Ian M. ADCOCK, Federica LO BELLO, Gaetano CARAMORI & Sharon MUMBY. (2022) New drugs under development for COPD. Minerva Medica 113:3.
Crossref
Gaetano CARAMORI. (2022) COPD: from bench to bedside. Minerva Medica 113:3.
Crossref
Francesco NUCERA, Sharon MUMBY, Keshav R. PAUDEL, Vivek DHARWAL, Antonino DI STEFANO, Vincenzo CASOLARO, Philip M. HANSBRO, Ian M. ADCOCK & Gaetano CARAMORI. (2022) Role of oxidative stress in the pathogenesis of COPD. Minerva Medica 113:3.
Crossref
Fabio PERROTTA, Vito D’AGNANO, Filippo SCIALÒ, Klara KOMICI, Valentino ALLOCCA, Francesco NUCERA, Rosario SALVI, Giulia M. STELLA & Andrea BIANCO. (2022) Evolving concepts in COPD and lung cancer: a narrative review. Minerva Medica 113:3.
Crossref
Gemilang Khusnurrokhman & Farah Fatma Wati. (2022) Tumor-promoting inflammation in lung cancer: A literature review. Annals of Medicine and Surgery 79, pages 104022.
Crossref
Lijie Wang, Ailing Liu, Zhiheng Wang, Ning Xu, Dandan Zhou, Tao Qu, Guiyuan Liu, Jingtao Wang, Fujun Yang, Xiaolei Guo, Weiwei Chi & Fuzhong Xue. (2022) A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population. Frontiers in Oncology 12.
Crossref
Amirhossein Fathinavid, Zaynab Mousavian, Ali Najafi, Sajjad Nematzadeh, Mahdieh Salimi & Ali Masoudi-Nejad. (2022) Identifying common signatures and potential therapeutic biomarkers in COPD and lung cancer using miRNA-mRNA co-expression networks. Informatics in Medicine Unlocked 34, pages 101115.
Crossref
Francesco Nucera, Phil M. Hansbro, Keshav Raj Paudel, Vincenzo Casolaro, Ramapraba Appanna, Paul Kirkham, Ian M. Adcock & Gaetano Caramori. 2022. Translational Autoimmunity. Translational Autoimmunity
311
331
.
Gaetano Caramori, Francesco Nucera, Irene Coppolino, Federica Lo Bello, Paolo Ruggeri, Kazuhiro Ito, Antonino Di Stefano & Ian M. Adcock. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
733
749
.
Jorge Ataucuri-Vargas, Ahmed Hussein & Humberto K. Choi. 2022. Lung Health and the Exposome. Lung Health and the Exposome
125
147
.
Xiaoshan Su, Junjie Chen, Xiaoping Lin, Xiaoyang Chen, Zhixing Zhu, Weijing Wu, Hai Lin, Jianming Wang, Xiangjia Ye & Yiming Zeng. (2021) FERMT3 mediates cigarette smoke-induced epithelial–mesenchymal transition through Wnt/β-catenin signaling. Respiratory Research 22:1.
Crossref
David A. Skerrett‐Byrne, Elizabeth G. Bromfield, Heather C. Murray, M. Fairuz B. Jamaluddin, Andrew G. Jarnicki, Michael Fricker, Ama T. Essilfie, Bernadette Jones, Tatt J. Haw, Daniel Hampsey, Amanda L. Anderson, Brett Nixon, Rodney J. Scott, Peter A. B. Wark, Matthew D. Dun & Philip M. Hansbro. (2021) Time‐resolved proteomic profiling of cigarette smoke‐induced experimental chronic obstructive pulmonary disease. Respirology 26:10, pages 960-973.
Crossref
Simin Abbasi, Nazanin Hosseinkhan, Nazanin Zahra Shafiei Jandaghi, Kaveh Sadeghi, Abbas Rahimi Foroushani, Seyed Abbas Hassani, Jila Yavarian & Talat Mokhtari Azad. (2021) Impact of human rhinoviruses on gene expression in pediatric patients with severe acute respiratory infection. Virus Research 300, pages 198408.
Crossref
Lin Zhou, Wenwen Gu, Fuguang Kui, Fan Gao, Yuji Niu, Wenwen Li, Yaru Zhang, Lijuan Guo, Junru Wang, Zhenzhen Guo & Gangjun Du. (2021) The mechanism and candidate compounds of aged citrus peel (chenpi) preventing chronic obstructive pulmonary disease and its progression to lung cancer. Food & Nutrition Research 65.
Crossref
Ti‐wei Miao, Wei Xiao, Long‐yi Du, Bing Mao, Wei Huang, Xue‐mei Chen, Cong Li, Yan Wang & Juan‐juan Fu. (2021)
High expression of
SPP1
in patients with chronic obstructive pulmonary disease (COPD) is correlated with increased risk of lung cancer
. FEBS Open Bio 11:4, pages 1237-1249.
Crossref
Shaopeng Zheng, Lintong Yao, Fasheng Li, Luyu Huang, Yunfang Yu, Zenan Lin, Hao Li, Jin Xia, Michael Lanuti & Haiyu Zhou. (2021) Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma. PeerJ 9, pages e10680.
Crossref
Yuting Cui, Mingyue Pan, Jing Ma, Xinhua Song, Weiling Cao & Peng Zhang. (2020) Recent progress in the use of mitochondrial membrane permeability transition pore in mitochondrial dysfunction-related disease therapies. Molecular and Cellular Biochemistry 476:1, pages 493-506.
Crossref
Phouthone Keohavong & Y. Peter Di. 2021. Lung Inflammation in Health and Disease, Volume I. Lung Inflammation in Health and Disease, Volume I
71
87
.
Carlo Baggio, Jalene V. Velazquez, Marco Fragai, Tara M. Nordgren & Maurizio Pellecchia. (2020) Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease. Journal of Medicinal Chemistry 63:21, pages 12911-12920.
Crossref
Keshav Raj Paudel, Vivek Dharwal, Vyoma K. Patel, Izabela Galvao, Ridhima Wadhwa, Vamshikrishna Malyla, Sj Sijie Shen, Kurtis F. Budden, Nicole G. Hansbro, Annalicia Vaughan, Ian A. Yang, Maija R J Kohonen-Corish, Mary Bebawy, Kamal Dua & Philip M. Hansbro. (2020) Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases. Frontiers in Medicine 7.
Crossref